Market Access Reports
Use patient-reported outcomes to guide product development and improve market access initiatives. Leverage the healthcare consumer perspective to strengthen product value propositions during regulatory approval and reimbursement discussions and to gain insight to potential commercial success.
Discover how life science companies build effective teams and efficient infrastructure to meet payers’ growing needs. Coordinate clinical, market access and medical affair groups to build successful managed markets organizations. Communicate consistent messages that justify current prices and present their products’ value to payers.
Benchmark your medical device HEOR group performance against your competitors, with real-company examples and case studies. Learn how HEOR teams can best support Class II and Class III medical devices throughout their lifecycle. This report will help you to define best practices for making the most out of your HEOR studies to drive reimbursement decisions.
Obtain hard-to-find Big Data benchmarks. Learn how top companies leverage health outcomes, social media, patient-reported outcomes and other real-world data to drive a broad range of prospective Big Data strategies.
Benchmark market access budgets, pinpoint ideal resource allocation and accurately measure success to prove the value of market access through tactical ROI calculations.
Learn strategies for building an efficient HOL team and discover best practices to get the best results out of payer interactions.
Build dedicated pharmaceutical pricing teams to manage a global market and increasing pharma regulations, and to embrace health economics and comparative effectiveness data.
Explore pharmaceutical launch sequencing factors, manage the impact of reference pricing and prepare for future growth in key emerging markets.
Use this report to win reimbursement, align HEOR with corporate objectives, and allocate resources across health economics priorities.
Win reimbursement, anticipate payer needs and build a superior US managed markets function.